Good manufacturing practice-grade cytotoxic T lymphocytes specific for latent membrane proteins (LMP)-1 and LMP2 for patients with Epstein-Barr virus-associated lymphoma

Cytotherapy. 2011 May;13(5):518-22. doi: 10.3109/14653249.2011.561983. Epub 2011 Mar 1.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antigen-Presenting Cells / immunology
  • Cell Culture Techniques
  • Cell Line, Tumor
  • Cell Separation / methods
  • Epstein-Barr Virus Infections / complications
  • Epstein-Barr Virus Infections / therapy*
  • Herpesvirus 4, Human / immunology*
  • Humans
  • Immunotherapy, Adoptive / methods*
  • Lymphoma / therapy*
  • Lymphoma / virology
  • T-Lymphocytes, Cytotoxic / immunology*
  • T-Lymphocytes, Cytotoxic / transplantation*
  • Transduction, Genetic
  • Viral Matrix Proteins / immunology*

Substances

  • EBV-associated membrane antigen, Epstein-Barr virus
  • Viral Matrix Proteins